State IN
Clinical Trials in Indiana
Recruiting clinical trials with at least one study location in Indiana. Data updated daily from ClinicalTrials.gov.
Top Conditions in Indiana
NCT06420141 N/A
Recruiting
The Prevalence of Neuropathic Pain Pathophysiology Associated With Ankle Fractur...
Condition
Neuropathic Pain
Enrollment
250 pts
Location
United States
Sponsor
Indiana University
NCT06683092 N/A
Recruiting
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
Condition
Cystic Fibrosis
Enrollment
200 pts
Location
United States
Sponsor
Boston Children's Hospital
NCT06636786 Phase 2
Recruiting
Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Subli...
Condition
Acute Stress Reaction
Enrollment
180 pts
Location
United States
Sponsor
University of North Carolina,
NCT06662786 Phase 3
Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or ...
Condition
Colorectal Neoplasms
Enrollment
1,000 pts
Location
United States, Belgium, Brazil
Sponsor
Janssen Research & Development
NCT07045051 N/A
Recruiting
Glycemic/Insulinemic Effects of Fresh Mango as a Sugar Substitute in Realistic B...
Condition
Healthy Participants
Enrollment
24 pts
Location
United States
Sponsor
Ball State University
NCT04553770 Phase 2
Recruiting
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatmen...
Condition
Early-stage Breast Cancer
Enrollment
88 pts
Location
United States
Sponsor
Jonsson Comprehensive Cancer C
NCT03547973 Phase 2
Recruiting
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Canno...
Condition
Metastatic Urothelial Cancer
Enrollment
827 pts
Location
United States, France, Germany
Sponsor
Gilead Sciences
NCT01804686 Phase 3
Recruiting
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Condition
Chronic Lymphocytic Leukemia
Enrollment
700 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
NCT06465810 N/A
Recruiting
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Condition
Transthyretin Amyloidosis
Enrollment
1,850 pts
Location
United States, Canada, China
Sponsor
AstraZeneca
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT05736354 N/A
Recruiting
Molecular Mechanisms Associated With Breast Implant Complications
Condition
Breast Implant; Complications
Enrollment
1,000 pts
Location
United States
Sponsor
Indiana University
NCT05213676 Phase 4
Recruiting
De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
Condition
Congenital Diaphragmatic Hernia
Enrollment
600 pts
Location
United States
Sponsor
The University of Texas Health
NCT07089888 Phase 3
Recruiting
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Condition
Tophaceous Gout
Enrollment
250 pts
Location
United States
Sponsor
Crystalys Therapeutics
NCT04128670 N/A
Recruiting
Effects of Kinesio Tape on Delayed Onset Muscle Soreness
Condition
Delayed Onset Muscle Soreness
Enrollment
36 pts
Location
United States
Sponsor
Indiana University
NCT06275360 Phase 2
Recruiting
Repositioning Immunotherapy in VetArans With Lung Cancer
Condition
Non-Small Cell Lung Cancer
Enrollment
25 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT02555280 N/A
Recruiting
Coflex PS3 Actual Conditions for Use Study
Condition
Spinal Stenosis Lumbar
Enrollment
300 pts
Location
United States
Sponsor
Xtant Medical
NCT05879913 N/A
Recruiting
ASCVD Management Using CCTA in Prostate Cancer Patients on ADT
Condition
Prostate Cancer
Enrollment
100 pts
Location
United States
Sponsor
Indiana University
NCT06149286 Phase 3
Recruiting
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works...
Condition
Relapsed/Refractory Follicular Lymphoma
Enrollment
470 pts
Location
United States, Australia, Austria
Sponsor
Regeneron Pharmaceuticals
NCT05275686 Phase 2
Recruiting
Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eusta...
Condition
Eustachian Tube Dysfunction
Enrollment
80 pts
Location
United States
Sponsor
Cedars-Sinai Medical Center
NCT06071624 Phase 1
Recruiting
Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second L...
Condition
Chronic Myelomonocytic Leukemia
Enrollment
30 pts
Location
United States
Sponsor
Huda Salman
NCT05733832 N/A
Recruiting
A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Dise...
Condition
Liver Diseases
Enrollment
1,000 pts
Location
United States
Sponsor
Indiana University
NCT05750498 N/A
Recruiting
A-LiNK: Improving Outcomes in Autoimmune Liver Disease
Condition
Autoimmune Hepatitis
Enrollment
800 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
NCT06081517 N/A
Recruiting
Evaluating Disparities in Precision Oncology
Condition
Metastatic Cancer
Enrollment
10,600 pts
Location
United States
Sponsor
Indiana University
NCT06532877 N/A
Recruiting
Telephone Support in Advanced Gastrointestinal Cancer
Condition
Gastrointestinal Neoplasm Malignant
Enrollment
488 pts
Location
United States
Sponsor
Indiana University
NCT06819007 Phase 3
Recruiting
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy ...
Condition
Ovarian Cancer
Enrollment
582 pts
Location
United States, Australia, Austria
Sponsor
Daiichi Sankyo